Table 5 Overall and ACPA-stratified haplotype association analysis for RA.

From: NFKB2 polymorphisms associate with the risk of developing rheumatoid arthritis and response to TNF inhibitors: Results from the REPAIR consortium

NFKB2

rs11574851

rs12769316

99999

Freq

RA patients (n = 4210) OR (95% CI)

P

Freq

ACPA-positive patients (n = 3117) OR (95% CI)

P

Freq

ACPA-negative patients (n = 2688) OR (95% CI)

P

1

C

C

 

0.8181

1.00

0.8224

1.00

0.8295

1.00

2

C

T

 

0.1139

1.14 (0.99–1.31)

0.066

0.1706

1.10 (0.92–1.32)

0.30

0.1088

1.02 (0.79–1.30)

0.91

3

T

T

 

0.0571

1.18 (0.98–1.42)

0.13

0.0530

1.39 (1.11–1.74)

0.0042

0.0538

1.04 (0.75–1.44)

0.82

4

T

C

 

0.0109

2.21 (1.37–3.56)

0.0011

  1. Estimates calculated according to a dominant model.
  2. Minimum haplotype frequency was set at 0.01. P < 0.05 in bold.